Arran Attridge Email

SVP, Corporate Communications . CymaBay Therapeutics

Current Roles

Employees:
51
Revenue:
$6.8M
About
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPAR agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with non-alcoholic steatohepatitis (NASH). For additional information about CymaBay visit www.cymabay.com.
CymaBay Therapeutics Address
7575 Gateway Blvd
Newark, CA
United States
CymaBay Therapeutics Email

Past Companies

CymaBay TherapeuticsVP, Corporate Communications
Gilead SciencesExecutive Director, Public Affairs - Virology
Gilead SciencesSenior Director, Public Affairs, COVID-19, Inflammation and Fibrosis

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.